Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
21 to 25 April 2005
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study conducted under GLP in accordance with an internationally recognised test guideline

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 413 (Subchronic Inhalation Toxicity: 90-Day Study)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.3465 (90-Day Inhalation Toxicity)
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Reference substance name:
Terracess TF
IUPAC Name:
Terracess TF
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Name of test material (as cited in study report): Terracess TF-S
- Appearance: white powder
- Purity: 99.6%
- Lot/batch No.: 4D90

Test animals

Species:
rat
Strain:
other: Crl:CD®(SD)IGS BR
Sex:
male/female

Administration / exposure

Route of administration:
inhalation
Type of inhalation exposure:
whole body
Vehicle:
air
Remarks on MMAD:
MMAD / GSD: The mass median aerodynamic equivalent diameter of the aerosols ranged from 2.5 to 2.9 μm.
Geometric standard deviations ranged from 1.3 to 1.6.
Details on inhalation exposure:
Mass median aerodynamic diameter: 2.5 to 2.9 microns
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
During each exposure, the atmospheric concentration of the test substance was determined by gravimetric analysis at approximately hourly intervals in the test chambers.
Duration of treatment / exposure:
Test duration: 90 days
Frequency of treatment:
Duration of exposure per day: 6 hours
Dosing regime: 5 days/week
Doses / concentrations
Remarks:
Doses / Concentrations:
2.0, 10, and 50 mg/m³
Basis:
analytical conc.
No. of animals per sex per dose:
20
Control animals:
yes, concurrent vehicle
Details on study design:
Four groups of 20 male and 15 female rats each were exposed to aerosols of Terracess TF-S dust at analytically determined concentrations of 2.0, 10, or 50 mg/m³. A similarly comprised control group of rats was simultaneously exposed to air only.

After the conclusion of the exposure phase there were 2 recovery periods of approximately 3 and 15 weeks. At the 3-week recovery, 5 male rats per group were sacrificed and given anatomic pathology examinations; the remaining male and female rats were sacrificed 15 weeks after exposure and also given anatomic pathology examinations.

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily

DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: during and after exposure + detailed observations once a week

BODY WEIGHT: Yes
- Time schedule for examinations: weekly

FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Yes

WATER CONSUMPTION: not applicable (not a drinking water study)

OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: prior to assignment to groups and at the end of the exposure period
- Dose groups that were examined all

HAEMATOLOGY: Yes
- Time schedule for collection of blood: at the end of the exposure period
- Anaesthetic used for blood collection: No data
- Animals fasted: Yes
- How many animals: 10 out of 20 per group

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at the end of the exposure period
- Animals fasted: Yes
- How many animals: 10 out of 20 per group
.
URINALYSIS: Yes
- Time schedule for collection of urine: at the end of the exposure period
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes

NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: near the end of the exposure period
- Dose groups that were examined: all
- Battery of functions tested: sensory activity / grip strength / motor activity
Sacrifice and pathology:
GROSS PATHOLOGY: Digestive System; Cardiovascular System; Musculoskeletal System; Hematopoietic System; Reproductive System; Urinary System;
Endocrine System; Respiratory System; Nervous System;

HISTOPATHOLOGY: Respiratory tract tissues were examined from all rats following the 90-day exposure. These respiratory tract tissues included the nose (4 cross sections), larynx and pharynx (2 cross sections), trachea (1 cross section) and lungs (cross sections of the right apical and caudal lobes; longitudinal section of the left lobe). For those rats selected for lung titanium analysis (5 males/exposure concentration/time point), only the left lung lobe was examined microscopically. In addition to non-polarized light, polarized light was used to examine all respiratory tissue in an effort to maximize identification of the test material within tissue sections.
Other examinations:
skin, and eyes (including optic nerve)
Statistics:
Significance was judged at p < 0.05. Separate analyses were performed on the data collected for each sex.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
no effects observed
Water consumption and compound intake (if drinking water study):
not examined
Description (incidence and severity):
not applicable (not a drinking water study)
Ophthalmological findings:
no effects observed
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Behaviour (functional findings):
no effects observed
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Description (incidence and severity):
A small increase in lung weight parameters was observed in high-concentration male rats after the 90-day exposure period.
Gross pathological findings:
effects observed, treatment-related
Description (incidence and severity):
One high-concentration male was noted to have mottled dark discoloration of the lungs at necropsy while one high-concentration female had diffuse white foci in the lungs, correlating with the microscopic aggregation of particulate-laden macrophages
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
no effects observed
Details on results:
Clinical observations:
There were no test-substance related adverse effects on mortality, body weights, clinical signs, neurobehaviour parameters or food consumption during the study. Clinical pathology evaluations showed no effects in haematology, coagulation, serum chemistry, or urine parameters as a result of exposure to Terracess TF-S dust.

Laboratory findings:
At each sacrifice period, sections of the lungs of 4 or 5 male rats per group were collected for titanium content to determine lung deposition and clearance of the test material. Based on this information, the clearance half times for Terracess TF-S were estimated to be in the order of 6 to 9 months for the 50mg/m3 group and 2 to 3 months for the 10 and 2 mg/m3 groups, respectively. These values are in the range of other insoluble, low toxicity dusts
like titanium dioxide.

Organ weight analyses at the end of the exposure period showed a statistically significant increase in lung-to-body weight ratios in the high-level males compared to controls. These differences were no longer present in male rats examined after 3- or 15-week recovery periods.

Effects in organs:
Histologic evaluation showed an exposure-related uptake of aerosol particulates by the resident pulmonary alveolar macrophages within the lung. There was no evidence of increased macrophage numbers, inflammation, or fibrosis. Male rats allowed to recover for 3 and 15 weeks showed migration of pulmonary macrophages into aggregates and gradual clearance of test material. The microscopic findings were consistent with exposure to a non-pathogenic, nuisance dust.

Effect levels

Key result
Dose descriptor:
NOAEL
Effect level:
0.01 mg/L air
Basis for effect level:
other: exposure duration: 6 hours/day

Target system / organ toxicity

Key result
Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
Under the conditions of the study, the no-effect level (NOAEL) for rats exposed to the test substance for approximately 90-days was 10 mg/cubic metre based on reversible lung weight effects in male rats at the highest exposure level.